Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-11
1998-02-24
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544289, A61K 31505, C07D23980
Patent
active
057212384
ABSTRACT:
2,8-Disubstituted quinazolinones are prepared by first subjecting the quinazolinone basic skeleton to condensation by customary reactions and then introducing the desired substituents into the 8-position. The compounds are suitable as active compounds in medicaments, in particular for the treatment of inflammations, thromboembolic diseases and cardiovascular diseases.
REFERENCES:
patent: 3169129 (1965-02-01), Rodgers et al.
patent: 4431440 (1984-02-01), Bhalla et al.
patent: 5294612 (1994-03-01), Bacon et al.
patent: 5482941 (1996-01-01), Terrett
S. Takano, et al., Heterocycles, vol. 29, No. 2, pp. 249-252, (1989).
M. Hoey, et al., Biochem. Pharmacol., vol. 40, pp. 193-202, (1990).
Bischoff Erwin
Hartwig Wolfgang
Heiker Fred Robert
Niewohner Ulrich
Perzborn Elisabeth
Bayer Aktiengesellschaft
Grumbling Matthew V.
LandOfFree
2,8-disubstituted quinazolinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,8-disubstituted quinazolinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,8-disubstituted quinazolinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875367